News
![Young lonely man in a wheelchair on a balcony looking at the nature in the spring](https://pharmaphorum.com/wp-content/uploads/2018/02/Boy-wheelchair.jpg)
Santhera seeks speedy FDA review of Duchenne drug vamorolone
Santhera has completed a rolling application for its Duchenne muscular dystrophy (DMD) therapy vamorolone in the US, setting up a possible approval and launch in the latter half of 2023.